Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion type Assertion NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_head.
- NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion description "[The diagnosis of therapy-related myeloid leukemia (t-MDS/t-AML) identifies a group of high-risk patients with multiple and varied poor prognostic features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_provenance.
- NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion evidence source_evidence_literature NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_provenance.
- NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion SIO_000772 18024664 NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_provenance.
- NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion wasDerivedFrom befree-2016 NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_provenance.
- NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_assertion wasGeneratedBy ECO_0000203 NP641141.RAleR4CsvNk9SBaZLyOuHfwoInW-V1B95rgyYOhNn3x58130_provenance.